Cargando…
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064029/ https://www.ncbi.nlm.nih.gov/pubmed/21447659 http://dx.doi.org/10.2337/dc11-0064 |
| _version_ | 1782200861670244352 |
|---|---|
| author | DeFronzo, Ralph A. |
| author_facet | DeFronzo, Ralph A. |
| author_sort | DeFronzo, Ralph A. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3064029 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30640292012-04-01 Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes DeFronzo, Ralph A. Diabetes Care Editorial Review American Diabetes Association 2011-04 2011-03-21 /pmc/articles/PMC3064029/ /pubmed/21447659 http://dx.doi.org/10.2337/dc11-0064 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Editorial Review DeFronzo, Ralph A. Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title | Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title_full | Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title_fullStr | Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title_full_unstemmed | Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title_short | Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes |
| title_sort | bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes |
| topic | Editorial Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064029/ https://www.ncbi.nlm.nih.gov/pubmed/21447659 http://dx.doi.org/10.2337/dc11-0064 |
| work_keys_str_mv | AT defronzoralpha bromocriptineasympatholyticd2dopamineagonistforthetreatmentoftype2diabetes |